Gut microbiota-mediated xanthine metabolism is associated with resistance to high-fat diet-induced obesity
Related Experiment Video
Updated: Nov 28, 2025

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
Bin Wei1, Sijia Wang1, Yakun Wang1
1College of Pharmaceutical Science & Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, China.
Abstract:
Resistance to high-fat diet-induced obesity (DIR) has been observed in mice fed a high-fat diet and may provide a potential approach for anti-obesity drug discovery. However, the metabolic status, gut microbiota composition, and its associations with DIR are still unclear. Here, ultraperformance liquid chromatography-tandem mass spectrometry-based urinary metabolomic and 16S rRNA gene sequencing-based fecal microbiome analyses were conducted to investigate the relationship between metabolic profile, gut microbiota composition, and body weight of C57BL/6J mice on chow or a high-fat diet for 8 weeks. PICRUSt analysis of 16S rRNA gene sequences predicted the functional metagenomes of gut bacteria. The results demonstrated that feeding a high-fat diet increased body weight and fasting blood glucose of high-fat diet-induced obesity (DIO) mice and altered the host-microbial co-metabolism and gut microbiota composition. In DIR mice, high-fat diet did not increase body weight while fasting blood glucose was increased significantly compared to chow fed mice. In DIR mice, the urinary metabolic pattern was shifted to a distinct direction compared to DIO mice, which was mainly contributed by xanthine. Moreover, high-fat diet caused gut microbiota dysbiosis in both DIO and DIR mice, but in DIR mice, the abundance of Bifidobacteriaceae, Roseburia, and Escherichia was not affected compared to mice fed a chow diet, which played an important role in the pathway coverage of FormylTHF biosynthesis I. Meanwhile, xanthine and pathway coverage of FormylTHF biosynthesis I showed significant positive correlations with mouse body weight. These findings suggest that gut microbiota-mediated xanthine metabolism correlates with resistance to high-fat DIO.
Insights
Mice resistant to high-fat diet-induced obesity (DIR) exhibit distinct metabolic profiles and gut microbiota compared to obese mice (DIO). Xanthine metabolism, influenced by gut bacteria, correlates with this resistance, offering potential anti-obesity strategies.
Area of Science:
- Metabolomics and Microbiomics
- Obesity Research
- Gut Microbiota and Host Metabolism
Background:
- High-fat diet-induced obesity (DIO) is a growing concern, yet mechanisms of resistance (DIR) remain unclear.
- Understanding the interplay between diet, metabolism, and gut microbiota in DIR is crucial for anti-obesity drug discovery.
- Previous studies have not fully elucidated the metabolic status and gut microbial composition in DIR mice.
Purpose of the Study:
- To investigate the relationship between metabolic profile, gut microbiota composition, and body weight in mice resistant to high-fat diet-induced obesity (DIR).
- To compare the metabolic and microbial characteristics of DIR mice with diet-induced obesity (DIO) and control mice.
- To identify potential biomarkers and pathways associated with resistance to diet-induced obesity.
Main Methods:
- C57BL/6J mice were fed either a chow or high-fat diet for 8 weeks.
- Urinary metabolomic analysis using ultraperformance liquid chromatography-tandem mass spectrometry.
- Fecal microbiome analysis using 16S rRNA gene sequencing and PICRUSt for functional metagenome prediction.
Main Results:
- High-fat diet increased body weight and fasting blood glucose in DIO mice, but not body weight in DIR mice.
- DIR mice exhibited a distinct urinary metabolic pattern compared to DIO mice, primarily driven by xanthine.
- Gut microbiota dysbiosis occurred in both DIO and DIR mice, but specific beneficial bacteria (Bifidobacteriaceae, Roseburia, Escherichia) were maintained in DIR mice, impacting FormylTHF biosynthesis I.
Conclusions:
- Gut microbiota composition and function are significantly altered in mice resistant to high-fat diet-induced obesity.
- Xanthine metabolism, influenced by gut microbiota, is a key factor associated with resistance to diet-induced obesity.
- Targeting gut microbiota-mediated xanthine metabolism may offer a novel therapeutic strategy for combating obesity.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

